Seysara

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 16110-247
  • Package NDC 16110-247-30
  • Application number NDA209521
  • SPL ID 4f9be4df-4e12-4f08-8e6f-cb07926ea5e6
  • SPL set ID b200957c-3004-4988-be97-9fd619a83649
  • UNII 36718856JR
  • RxCUI 2059023
  • RxCUI 2059029
  • RxCUI 2059031
  • RxCUI 2059033
  • RxCUI 2059035
  • RxCUI 2059037

What the source publishes

Labeler
Almirall, LLC
Active ingredients
sarecycline hydrochloride
Form
TABLET, COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6
{
  "name": "Seysara",
  "splId": "4f9be4df-4e12-4f08-8e6f-cb07926ea5e6",
  "labels": [
    {
      "setId": "b200957c-3004-4988-be97-9fd619a83649",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b200957c-3004-4988-be97-9fd619a83649",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b200957c-3004-4988-be97-9fd619a83649"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Almirall, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, COATED in 1 BOTTLE (16110-247-30)",
      "package_ndc": "16110-247-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190104"
    }
  ],
  "productId": "16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6",
  "useDomain": "unknown",
  "dosageForm": "TABLET, COATED",
  "productNdc": "16110-247",
  "deaSchedule": null,
  "genericName": "sarecycline hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SARECYCLINE HYDROCHLORIDE",
      "strength": "150 mg/1"
    }
  ],
  "applicationNumber": "NDA209521",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190104",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0316110245300",
      "0316110246307"
    ],
    "unii": [
      "36718856JR"
    ],
    "rxcui": [
      "2059023",
      "2059029",
      "2059031",
      "2059033",
      "2059035",
      "2059037"
    ],
    "spl_set_id": [
      "b200957c-3004-4988-be97-9fd619a83649"
    ],
    "manufacturer_name": [
      "Almirall, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6"